Information Society in PharmaceuticalsOrganizations contemplate information technology and the Internet as a unique opportunity to enhance knowledge work and to improve quality of service. Electronic regulatory reporting, electronic document archival and data retrieval, automatic transactions between collaborative enterprise resources, wide availability and dissemination of information to the public; these are a few of the facets enabled by the information society and the digital revolution. |
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Common terms and phrases
accept activities administration adverse Agency allow application associated authorisation authorities CDER changes clinical coding communication companies consumers contain database defined definition described dictionary Directive documents drug E-mail electronic submission elements EMEA environment EudraNet European Evaluation event exchange field format global Governments Group ICSR identify implementation important individual industry initiatives integrated International Internet involved issues Japan joint pilot language major marketing MedDRA medicinal products Member organ organisations participants particular pharmaceutical pharmaceutical companies pharmaceutical industry pharmacovigilance possible practices present procedures provides reaction received refer regulators regulatory Research result rules safety reports secure sender specific standards step structure Study submitted Table technical terminology tracking transmission types United updates users validation
Bibliographic information
| Title | Information Society in Pharmaceuticals Volume 4 of Pharmaceuticals policy and law, ISSN 1389-2827 Volume 4 of Pharmaceuticals policy and law, ISSN 1389-2827 |
| Author | José Luis Valverde |
| Edition | illustrated |
| Publisher | IOS Press, 2001 |
| ISBN | 1586031783, 9781586031787 |
| Length | 138 pages |
| Export Citation | BiBTeX EndNote RefMan |